These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 7162468
1. Mode of action of 1-beta-D-arabinofuranosylcytosine in human lymphoblasts: differential effects of the drug on chromosomal replication. Fridland A. Med Pediatr Oncol; 1982; 10 Suppl 1():69-79. PubMed ID: 7162468 [Abstract] [Full Text] [Related]
2. Inhibition of deoxyribonucleic acid chain initiation: a new mode of action for 1-beta-D-arabinofuranosylcytosine in human lymphoblasts. Fridland A. Biochemistry; 1977 Nov 29; 16(24):5308-12. PubMed ID: 921933 [Abstract] [Full Text] [Related]
3. Mode of action of 9-beta-D-arabinosyladenine and 1-beta-D-arabinosylcytosine on DNA synthesis in human lymphoblasts. Bell DE, Fridland A. Biochim Biophys Acta; 1980 Nov 29; 606(1):57-66. PubMed ID: 6965455 [Abstract] [Full Text] [Related]
4. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution. Ross DD, Chen SR, Cuddy DP. Cancer Res; 1990 May 01; 50(9):2658-66. PubMed ID: 2328491 [Abstract] [Full Text] [Related]
7. Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine. Ross DD, Cuddy DP, Cohen N, Hensley DR. Cancer Chemother Pharmacol; 1992 May 01; 31(1):61-70. PubMed ID: 1458561 [Abstract] [Full Text] [Related]
9. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome. Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH. Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808 [Abstract] [Full Text] [Related]
10. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin. Fram RJ, Kufe DW. Cancer Res; 1982 Oct 15; 42(10):4050-3. PubMed ID: 6809309 [Abstract] [Full Text] [Related]
11. Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts. Shewach DS, Daddona PE, Ashcraft E, Mitchell BS. Cancer Res; 1985 Mar 15; 45(3):1008-14. PubMed ID: 3971358 [Abstract] [Full Text] [Related]
12. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function. Kufe DW, Munroe D, Herrick D, Egan E, Spriggs D. Mol Pharmacol; 1984 Jul 15; 26(1):128-34. PubMed ID: 6431261 [Abstract] [Full Text] [Related]
16. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism. Karp JE, Donehower RC, Dole GB, Burke PJ. Cancer Res; 1984 Nov 15; 44(11):5046-50. PubMed ID: 6488163 [Abstract] [Full Text] [Related]
17. Antiviral effect of antileukemic drugs N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) and 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine (cyclo-C) against human cytomegalovirus. Nakamura K, Eizuru Y, Kumura K, Minamishima Y. J Med Virol; 1990 Jun 15; 31(2):141-7. PubMed ID: 1696958 [Abstract] [Full Text] [Related]
20. A novel in vitro model system for studying the action of ara-C. Wills P, Hickey R, Ross D, Cuddy D, Malkas L. Cancer Chemother Pharmacol; 1996 Jun 15; 38(4):366-72. PubMed ID: 8674160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]